VTGN

Vistagen Therapeutics, Inc.

Allerton Avenue South San Francisco , California • FY2026 Annual Report

NYSE H-1B Visa Sponsor Revenue +161.1% YoY

Revenue

$1M

Net Income

$-70M

EBIT Margin

-5546.2%

Diluted EPS

$-1.83

Free Cash Flow

$-66M

CEO Pay

$2,477,682

Shawn K. Singh, J.D.

$2,477,682

Shawn K. Singh, J.D.'s total compensation in FY2026

Base salary $650,000 • Stock awards $1. The CEO's pay package is funded by the same company that claims it cannot find qualified American workers for its open positions.

Financial Snapshot — FY2026

Total Revenue

$1M

+161.1% year-over-year

Net Income

$-70M

Operating Margin

-5546.2%

Diluted EPS

$-1.83

Free Cash Flow

$-66M

Dividend / Share

N/A

Stock Buybacks

N/A

What We Pay the Executives Source: SEC DEF 14A via sec-api.io

CEO Total Compensation

$2,477,682

Shawn K. Singh, J.D.

CEO Base Salary

$650,000

CEO Stock Awards

Avg. Other NEO Total

$1,113,838

Executive	Title	Base Salary	Stock Awards	Total Comp
Shawn K. Singh, J.D.🔍	President, Chief Executive Officer and Director	$650,000	$1	$2,477,682
Reid G. Adler, J.D.🔍	Chief Legal Officer	$450,000	$1	$1,175,807
Cynthia L. Anderson, CPA🔍	Chief Financial Officer and Treasurer	$443,750	$1	$1,107,456
Joshua S. Prince, MBA🔍	Chief Operating Officer	$410,000	$1	$1,058,250

SCT = Summary Compensation Table totals from SEC EDGAR DEF 14A proxy statement.

Board of Directors — Who Enables This

Director	Role	Age	Independent	Since	Tenure	Annual Pay	Committees
Ann Cunningham, MBA🔍	Director	None	Yes	N/A	N/A	N/A
Elissa Cote🔍	Chief Corporate Development Officer	50	Yes	N/A	N/A	N/A
Jerry B. Gin, Ph.D.🔍	Director	None	Yes	N/A	N/A	N/A	Compensation Committee, Audit Committee
Joanne Curley, Ph.D.🔍	Independent Director	57	Yes	N/A	N/A	N/A	Corporate Governanceand Nominating Committee
Jon S. Saxe, J.D., LL.M.🔍	Independent Director	89	Yes	N/A	N/A	N/A	Corporate Governanceand Nominating Committee, Audit Committee
Margaret M. FitzPatrick🔍	Chair and Independent Director	59	Yes	N/A	N/A	N/A	Corporate Governance and Nominating Committee, Compensation Committee
Margaret M. FitzPatrick, M.A.🔍	Director	None	Yes	N/A	N/A	N/A	Compensation Committee, Audit Committee
Mary L. Rotunno, J.D.🔍	Independent Director	65	Yes	N/A	N/A	N/A	Compensation Committee
Ms. Cunningham🔍	Chief Commercial Officer	None	Yes	N/A	N/A	N/A	Corporate Governance and Nominating Committee
Reid G. Adler, J.D.🔍	Chief Legal Officer	71	No	N/A	N/A	N/A
Shawn K. Singh, J.D.🔍	President, Chief Executive Officer and Director	62	No	N/A	N/A	N/A

Source: SEC EDGAR DEF 14A proxy statement via sec-api.io.

H-1B Visa Dependency Key Metric

Search all Vistagen Therapeutics, Inc. H-1B Labor Condition Applications filed with the U.S. Dept. of Labor.

🔍 Search H-1B Records for Vistagen Therapeutics, Inc.

Source: U.S. Dept. of Labor OFLC disclosure data. LCA filing does not guarantee a visa was issued.

Shareholder Value Assessment

PositiveRevenue grew 161.1% year-over-year - strong growth.

ConcernCompany is operating at a net loss.

PositiveCEO compensation of $2.5M is within range for company size.

Key Business Risks (from 10-K Item 1A)

Patient enrollment and randomization in a clinical trial is affected by many factors, including — • the patient eligibility criteria defined in the protocol for such clinical trial;
Changes in methods of product candidate manufacturing or formulation may result in additional costs or delay — As product candidates proceed through preclinical studies and clinical trials towards pot
Factors that may inhibit our efforts to commercialize our product candidates on our own include — • lack of sufficient capital resources available to us in a timely manner, if at all, and on com
Remote working arrangements could significantly increase our digital and cybersecurity risks — Most of our employees are geographically dispersed from our headquarters facility in South San Francisco
Additional laws and regulations governing international operations could negatively impact or restrict our operations — If we expand our operations outside of the U.S., we must dedicate additional res

♥

Help Support This Research

This analysis is produced independently — one person, 23 years of data work, living on $1,419/month Social Security. If these reports help you understand how H-1B visas affect American workers, a small donation makes a real difference.

♥ Donate via Square More Reports

Vistagen Therapeutics, Inc.

Shawn K. Singh, J.D.'s total compensation in FY2026

Help Support This Research

💬 Comments & Discussion